Skip to content

HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing

HOME Study: Evaluation of a Combination Support Package to Increase Uptake of Pre-exposure Prophylaxis and HIV/STI Testing Among Young Black and Latino MSM in the San Francisco Bay Area.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03138135
Enrollment
104
Registered
2017-05-03
Start date
2017-01-09
Completion date
2018-11-30
Last updated
2021-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Prevention, Pre-Exposure Prophylaxis, Sexually Transmitted Diseases

Keywords

PrEP, HIV prevention, Risk reduction, STI prevention, Home HIV testing, HIV testing, STI testing

Brief summary

Home HIV self-testing has been FDA approved and allows users to read their own HIV test results at home, while home sexually transmitted infection (STI) test self-collection allows men to use a swab at home and mail it in for testing. The purpose of this study is to learn how Men who have Sex with Men (MSM) use these new testing options, a set of online support tools, and the option to test with someone to support them (a testing buddy). We will also evaluate whether the online tools help these men to connect with HIV prevention services such as Pre-Exposure Prophylaxis (PrEP) if they test HIV negative, and to HIV care services if they test HIV positive.

Detailed description

Participants will be randomized 2:1 after enrollment to the intervention and control condition. Data obtained from this study will be used to inform the further tailoring and distribution of an intervention for young Black and Latino MSM to increase utilization of home HIV self-testing and linkage to HIV treatment and Pre-Exposure Prophylaxis (PrEP).

Interventions

BEHAVIORALHOME Study intervention

Access to home HIV test kits, home STI self-collection kits, the HOME Study website, and the SexPro HIV risk assessment tool.

BEHAVIORALControl

Counseling about the importance of quarterly HIV/STI testing and a PrEP information pamphlet.

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
San Francisco Department of Public Health
CollaboratorOTHER_GOV
University of California, San Francisco
CollaboratorOTHER
Public Health Foundation Enterprises, Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Self-identify as Black or Latino. * Report anal sex with at least one male sex partner in the prior 12 months. * HIV negative by self-report. * Currently own a cell phone. * Willing and able to provide written informed consent.

Exclusion criteria

* Inadequate contact information for follow-up. * In a mutually monogamous sexual relationship for the past 12 months. * Currently taking PrEP. * Does not have reliable access to the Internet. * Does not live, work, or play in the San Francisco Bay Area. * Planning to move out of the Bay Area during the 9 month study period. * Previously participated in the HOME Pilot study. * Any medical, psychiatric, or social condition, or occupational, or other responsibility that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of the HOME package to support linkage to PrEP or HIV care9 monthsBetween-arm differences in initiation of PrEP; qualitative evaluation of linkage to HIV care.
Efficacy of the HOME package to increase HIV and STI testing frequency.9 monthsThe proportion of participants reporting HIV and STI testing rates between visits.

Secondary

MeasureTime frameDescription
Feasibility of the individual components of the study intervention.9 monthsCombined analysis of overall use of study intervention: Usage of home HIV self-testing, with and without buddies, as well as STI-self collection; Proportion of participants who log-in to the HOME Study site at least once, distribution of numbers of log-ins, and use of HOME Study pages, as measured by numbers of clicks and views for each page.
Acceptability of the HOME package to support linkage to HIV care or PrEP.9 monthsAcceptability scores from online questionnaires and the distribution of repeated scores at follow-up timepoints.

Other

MeasureTime frameDescription
Who uses a buddy.9 monthsDifferences in testing with a buddy by occasion, age, county, race/ethnicity, and prior testing history. Aggregate descriptive analysis.
Use of HIV prevention services.9 monthsProportion of HIV uninfected participants who attend group or individual counseling services.
Who uses home HIV self-testing and home STI self-collection.9 monthsTesting and self-collection rates by occasion, age, county, race/ethnicity, and prior testing history. Aggregate descriptive analysis.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026